Furthermore, BFSP1 methylation and expression levels were significantly associated with various clinicopathological features such as primary tumor status, pathological stage (I–IV), histological grade (I–IV), and TP53 mutation status (Figure 3B). This evidence concerns the gene BFSP1 and neoplasm.